The study for new therapy of endotoxin shock
The study for new therapy of endotoxin shock
批准号:
60480291
负责人:
KODAMA Masashi
金额:
$3.52万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1985
资助国家:
日本
项目状态:
已结题
起止时间:
1985 至 1986
中文摘要
我们能够通过缩合或诱导其与卤素反应来固定多粘菌素B。在缩合反应后,一克聚苯乙烯纤维上附着的多粘菌素B的剂量比卤素反应后要大得多。发现固定多粘菌素B牢固地附着在纤维上。注射含有内毒素的PMX-F处理液后小鼠的死亡率表明,处理组有24%(21只中的5只)存活。而未经治疗的21人中有21人100%死亡。在离体实验中,对内毒素注射犬进行了PMX-F直接血液灌流(DHP)。对照组只有12.5%(1 / 8)存活,而接受DHP + PMX-F治疗组有83%(10 / 12)存活。治疗组死亡率明显降低。结果表明,PMX-F具有中和内毒素的作用。对于临床应用,PMX-F正在评估血液相容性与大柱人。使用PMX-F检测DHP时,肝素用量比早期检测时少。该剂量的肝素在动物体内可安全驱动DHP。
英文摘要
We were able to immobilize Polymyxin B through condensation or by inducing in to react with halogen. A much larger dose of Polymyxin B adhered to one gr of polystyrene fiber after the condensation reaction than it did following the halogen reaction. Fixed polymyxin B was found to be firmly attached to the fiber. The mortality of mice after injection of PMX-F treated fluid contained endotoxin, indicated that 24 % (5 of 21) of the treated group survived. Whereas 100 % (21 of 21) of the untreated group died. In ex vivo experiments, direct hemoperfusion (DHP) by PMX-F was performed for endotoxin-injected canine. Only 12.5 % (1 of 8) survived in the control group, but 83 % (10 of 12) survived in the treated group receiving DHP with PMX-F. Mortality in the treated group decreased remarkably. The results thus indicated the efficacy of PMX-F in neutralizing endotoxin.For the clinical application, PMX-F is being estimated blood compatibility with larger column for human. And DHP using PMX-F is tried by smaller amount of heparin than that of earlier examination. DHP can be driven safely with this quantity of heparin in animal.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
小玉正智 他: 人工臓器.
Masatomo Kodama 等人:人造器官。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
小玉正智 他: 人工臓器. 14. 590-594 (1985)
Masatomo Kodama 等:人工器官。14. 590-594 (1985)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
小玉正智 他: 免疫と血液. 7. 427-432 (1985)
Masatomo Kodama 等人:免疫与血液。7. 427-432 (1985)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M.Kodama;T.Yoshioka;Y.Endo;T.Tani;K.Hanasawa;T.Oka;K.Matsuda: Journal of Immunology and Immunopharmacology. 6. 224 (1986)
M.Kodama;T.Yoshioka;Y.Endo;T.Tani;K.Hanasawa;T.Oka;K.Matsuda:免疫学和免疫药理学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M. Kodama et al.: "Studies on Prevention to MOF -Removal of Endotoxin in Serum on Hepatic Disorder" Jpn. J. Artif Organs. 14. 590-594 (1985)
M. Kodama等:“预防MOF的研究-肝脏疾病血清中内毒素的去除”Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 12 条
Development of Hybrid Artificial Liver with Isolated Hepatocytes in Extracorporeal Circulation
-
批准号:06454381
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.16万
-
财政年份:1994
-
负责人:KODAMA Masashi
-
依托单位:
Studies on the Inhibitory Effect of Blood Transfusion Against Anti-Tumor Immunity
-
批准号:01480312
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1989
-
负责人:KODAMA Masashi
-
依托单位:
evaluation and invention of endotoxin detoxifying material for clinical application
-
批准号:62870051
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$13.82万
-
财政年份:1987
-
负责人:KODAMA Masashi
-
依托单位:
Study on the mechanical analysis of septic shock and its theraputic strategy
-
批准号:62480271
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1987
-
负责人:KODAMA Masashi
-
依托单位:
海外基金